Benitec Biopharma Inc. (BNTC) vs Fate Therapeutics, Inc. (FATE)
A side-by-side comparison of Benitec Biopharma Inc. and Fate Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.
BNTC
Benitec Biopharma Inc.
$8.87HealthcareDelayed quote: Oct 6, 2026, 10:44 AM EDT
FATE
Fate Therapeutics, Inc.
$2.34HealthcareDelayed quote: Oct 6, 2026, 10:40 AM EDT
Total return — BNTC vs FATE
growth of $100 · dividends reinvested · last 10yBNTC -97.4% (-30.5%/yr)FATE -22.1% (-2.5%/yr)FATE compounded faster over this window
Log scale — wide-divergence pair
BNTC FATE
BNTC vs FATE: by the numbers
- •BNTC is the larger company ($305M vs $272M market cap).
- •Both run net losses; BNTC's is the smaller (0.00% vs -1941.09% net margin).
Metrics side by side
Valuation
| Metric | BNTC | FATE |
|---|---|---|
| P/S ratio | N/A | 41.93 |
| P/B ratio | 1.72 | 1.77 |
Profitability
| Metric | BNTC | FATE |
|---|---|---|
| Gross margin | 0.00% | -94.12% |
| Operating margin | 0.00% | -2222.45% |
| Net margin | 0.00% | -1941.09% |
| ROE | -25.73% | -82.12% |
| ROIC | -28.88% | -58.72% |
Growth (annualized)
| Metric | BNTC | FATE |
|---|---|---|
| Revenue CAGR (5Y) | N/A | -32.98% |
| Total return CAGR (5Y) | -31.08% | -46.86% |
Frequently asked
- How have BNTC and FATE total returns compared?
- Over the past 10 years, BNTC delivered -30.49% and FATE delivered -2.31% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.